Sutro Biopharma, Inc. (STRO) News
Follow Sutro Biopharma, Inc. (STRO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) NASDAQ:STRO, a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugat
NEWS | Sep 29, 2026, 12:09 PM UTC
L
STRO: Accelerated ADC pipeline shows strong efficacy, safety, and innovation in dual payload strategies
Three clinical programs are advancing rapidly, with STRO-004 showing strong early efficacy and safety across multiple tumor types. Dual payload ADCs demonstrate potential to overcome resistance, supported by robust precl
NEWS | Sep 15, 2026, 04:16 PM UTC
L
STRO Reports Q2 2026 Financial Results
STRO reports second quarter 2026 financial results and provides update on STRO-004 Phase 1 study
EARNINGS | Aug 12, 2026, 11:00 AM UTC